Trademark: 79335233
Status Date
Tuesday, January 3, 2023
Registration Number
6938323
Registration Date
Tuesday, January 3, 2023
Filing Date
Tuesday, July 13, 2021
Published for Opposition
Tuesday, October 18, 2022
5 Pharmaceuticals, namely, pharmaceutical preparations for the treatment of cancer and neurological diseases; medical and veterinary preparations for treatment of cancer and neurological diseases; sanitary preparations for medical purposes; dietetic food and dietetic preparations adapted for medical or veterinary use; dietary supplements for human beings and animals; dietary supplements; pharmaceuticals for use in oncology for the treatment of cancer and neurological diseases
1 Chemicals for use in biotechnological product development; chemicals for use in biotechnological manufacturing processes; chemical preparations, namely, biologically compatible chemical substances for scientific, laboratory, clinical and medical research; biological tissue, namely, mammalian soft and hard tissues comprising or derived from stem cells or progenitor cells for scientific, laboratory, clinical and medical research; biological tissue, namely, biological tissue comprising or derived from stem cells or progenitor cells, and compositions thereof, for scientific, laboratory, clinical and medical research
44 Medical services; diagnostic and prognostic medical services; veterinary services; medical analysis services relating to the treatment of persons; pharmaceutical advice; medical and health services relating to antibodies, immuno-oncology, inflammation, haematology and infectious disease, namely, medical diagnostic testing, monitoring and reporting services; medical screening and assaying in the nature of medical testing for diagnostic or treatment purposes
42 Drug discovery and pharmaceutical drug development services; scientific services in the nature of scientific research, analysis, and testing in the field of pharmaceuticals and research, development and design relating thereto; medical research; technological services in the nature of pharmaceutical products development and technical consulting in the field of pharmaceutical studies and research and design relating thereto; product design and development of medical technology; product design and development of medical diagnostic apparatus; consultancy services in the field of technological development in the field of medical technology and pharmaceuticals; industrial analysis and industrial research services in the field of medical technology and pharmaceuticals; design and development of computer hardware and software; design and development of software; clinical research, namely, conducting clinical trials for others; pharmaceutical research and development; development of pharmaceutical preparations and medicines; research and development services in the field of antibodies, immuno-oncology, inflammation, haematology and infectious disease; medical and scientific research, namely, conducting clinical trials for others; conducting clinical trials for pharmaceutical products for others; scientific screening and assaying, namely, scientific research; chemical analysis; chemical research; biotechnology research; consultancy in the field of biotechnology
May 17, 2023
Final Decision Transaction Processed By Ib
Apr 20, 2023
Final Disposition Notice Sent To Ib
Apr 20, 2023
Final Disposition Processed
Apr 3, 2023
Final Disposition Notice Created, To Be Sent To Ib
Apr 2, 2023
New Representative At Ib Received
Jan 29, 2023
New Representative At Ib Received
Jan 3, 2023
Notice Of Registration Confirmation Emailed
Jan 3, 2023
Registered-Principal Register
Oct 18, 2022
Official Gazette Publication Confirmation E-Mailed
Oct 18, 2022
Published For Opposition
Sep 28, 2022
Notification Of Notice Of Publication E-Mailed
Sep 15, 2022
Approved For Pub - Principal Register
Sep 8, 2022
Preliminary/Voluntary Amendment - Entered
Sep 8, 2022
Teas Voluntary Amendment Received
Sep 7, 2022
Teas/Email Correspondence Entered
Sep 7, 2022
Correspondence Received In Law Office
Sep 7, 2022
Teas Response To Office Action Received
Jun 7, 2022
Refusal Processed By Ib
May 16, 2022
Non-Final Action Mailed - Refusal Sent To Ib
May 16, 2022
Refusal Processed By Mpu
Apr 3, 2022
Non-Final Action (Ib Refusal) Prepared For Review
Apr 2, 2022
Non-Final Action Written
Mar 31, 2022
Assigned To Examiner
Mar 15, 2022
Application Filing Receipt Mailed
Mar 11, 2022
New Application Office Supplied Data Entered
Mar 10, 2022
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
